In January 2026, 10x Genomics, Inc. reported preliminary 2025 results showing about US$166.0 million in fourth-quarter ...
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...
CareDx recently issued preliminary, unaudited guidance for fourth-quarter 2025 revenue of about US$108 million and full-year ...
How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.
Demonstrating faster, simpler, more cost-efficient NGS workflows that turn complex agrigenomics data into practical ...
Illumina has named Eric Green as chief medical officer, providing a home to the first National Institutes of Health director ...
Enhanced Genomics ('Enhanced' or 'the Company'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for co ...
Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...
India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...
Mapping the genomes of the bacteria responsible for yaws, a debilitating childhood disease, has uncovered new insights into ...
Enhanced Genomics has announced the appointment of Dr Katerina Leftheris to its Board of Directors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results